(HealthDay News) – For lung transplant recipients, 25-hydroxyvitamin D (25[OH]D) deficiency is associated with increased incidence of acute rejection and infection, and deficiency at one year after transplant is linked with increased mortality.
To investigate the correlation between vitamin D levels and outcomes after lung transplant, Erin M. Lowery, MD, from the Loyola University Medical Center in Maywood, IL, and colleagues reviewed data from a cohort of 102 lung transplant recipients. All participants had 25(OH)D levels drawn within 100 days before or after transplant.
The researchers found that, in the near-transplant period, 80% of lung transplant recipients were 25(OH)D deficient and 20% were not deficient. Compared with the non-deficient group, the deficient group experienced more frequent episodes of acute cellular rejection (mean, 1.27 vs. 0.52), had a higher rejection rate (incident rate ratio [IRR], 2.43), and experienced more frequent infectious episodes (mean, 4.01 vs. 2.71). Patients who remained deficient at one year post-transplant had a significantly higher mortality rate than those who were not 25(OH)D deficient (IRR, 4.79).
“We assert that there are multiple benefits to maintaining normal serum vitamin D levels in the lung transplant population, such as decreased frequency of acute rejection and infection and an overall survival benefit,” the authors write.
Full Text (subscription or payment may be required)